Document:

Exhibit
      10.29

    

    SECOND
      NOTE EXTENSION AGREEMENT

    

    

    This
      Second Note Extension Agreement (“Agreement”) is entered into this 30th day of
      May 2008, by Dr. Tattoff, Inc. (the “Company”), a Florida corporation, and each
      of the undersigned noteholders (collectively, “Noteholders”).

    

    

    BACKGROUND

    

    WHEREAS,
      the
      DRTATTOFF, LLC (“Dr. Tattoff”) has previously issued to the Noteholders certain
      promissory notes more particularly described in Annex
      A
      attached
      hereto, all of which matured on December 1, 2007 (collectively, “Notes”);

    

    WHEREAS,
      Dr. Tattoff and each of the Noteholders entered into a Note Extension Agreement
      dated December 20, 2007, whereby the maturity date of the Notes was extended
      to
      June 1, 2008; 

    

    WHEREAS,
      the Company assumed the obligations of Dr. Tattoff under the Notes in connection
      with the merger, whereby Dr. Tattoff merged with and into the Company on
      February 11, 2008; and

    

    WHEREAS,
      the Company has requested, and each of the Noteholders has agreed, to extend
      the
      respective maturity dates of the Notes and reaffirm their waiver of any and
      all
      past defaults.

    

    NOW,
      THEREFORE, in consideration of the foregoing, of the mutual agreements
      hereinafter set forth, and of other good and valuable consideration, the receipt
      and sufficiency of which are hereby acknowledged, the parties hereto hereby
      agree follows:

    

    1.  The
      parties agree that the Recitals set forth above are true and correct and are
      incorporated into this Agreement by reference. 

    

    2. Each
      Noteholder hereby agrees, the maturity date (“Maturity Date”) for each of the
      Notes is hereby extended to the earlier of: (a) December 1, 2008, or (b) sixty
      (60) calendar days from the date a registration statement registering the
      securities of the Company for public sale is declared effective by the
      Securities and Exchange Commission. Except as provided herein, all other terms
      of the Notes are ratified and confirmed.

    

    3. The
      parties hereto agree that the unpaid principal balance of the Notes shall bear
      interest at the rate of ten percent (10%) per annum beginning June 1, 2008
      until
      the Maturity Date. The amount of interest to be paid on the daily outstanding
      balance of principal evidenced by the Notes shall be based upon a 365-day year
      for the actual number of days for which interest is payable, but such interest
      shall never exceed the maximum rate of interest permitted under applicable
      law

    

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    4.
       Each
      Noteholder hereby affirms their waiver of any and all past defaults, late
      charges (including default interest rates) and penalties under the Notes, if
      any, in their entirety.

    

    5. This
      Agreement shall bind and inure to the benefit of the parties hereto, their
      respective successors and permitted assigns.

    

    6. This
      Agreement may be executed in any number of counterparts, each of which shall
      constitute an original, and all of which, taken together, shall constitute
      the
      same instrument.

    

    7.
       This
      Agreement may be executed by facsimile signature and that such facsimile
      signature shall have the same effect as original signatures.

    

    

    [Signature
      Page Follows]

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

    IN
      WITNESS WHEREOF, the parties have executed this Agreement as of the day and
      year
      first above written.

    

      	 	 	 
	 	Dr.
              Tattoff, Inc.
	 
 	 
 	 
 
	 	By:  	/s/ John
              Keefe
	 	
              
Name:
              John Keefe
	 	Title:
              Chief Executive Officer

    

    

    ACCEPTED
      AND APPROVED:

    

    
      	 	 	 	 
	/s/ James
              Morel	 	 	 
	
              
James
              Morel	 	 	
            
	 	 	 	 
	 	 	 	 
	/s/ William Kirby	 	 	 
	
              
William
              Kirby	 	 	 
	 	 	 	 
	 	 	 	 
	/s/ Christopher Knight	 	 	 
	
              
Christopher
              Knight	 	 	 
	 	 	 	 
	 	 	 	 
	/s/ John J. Klobnak	 	 	 
	
              
John
              J. Klobnak	 	 	 

    

     

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    Annex
      A

    

    

    
      	
              Principal
                Amount

            	
              Holder

            	
              Original

              Maturity
                Date

            
	 	 	 
	
              $3,000
                

            	
              James
                Morel

            	
              12/1/2007

            
	
              $20,000
                

            	
              William
                Kirby

            	
              12/1/2007

            
	
              $21,000
                

            	
              Christopher
                Knight

            	
              12/1/2007

            
	
              $20,000
                

            	
              John
                J. Klobnak

            	
              12/1/2007

            

    

    

    
      
         

      

      
        4Exhibit
      10.30

     

    NEITHER
      THIS SECURITY NOR THE SECURITY INTO WHICH THIS SECURITY IS EXERCISABLE HAVE
      BEEN
      REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES
      COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER
      THE SECURITIES ACT OF 1933, AS AMENDED, AND, ACCORDINGLY, MAY NOT BE OFFERED
      OR
      SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES
      ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT
      TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH
      APPLICABLE STATE SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL
      TO
      THE TRANSFEROR TO SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY
      ACCEPTABLE TO THE COMPANY.

     

    

    Warrant
      No. February 08-21

    

    

    Void
      after 5:00 p.m., Eastern Standard Time on February 11, 2013

    

    COMMON
      STOCK PURCHASE WARRANT

    

    

    Lifesciences
      Opportunities Incorporated, a Florida corporation (the “Company”),
      hereby certifies that, for value received,
      Howard
      Sampson
      (the
“Warrant
      Holder”)
      is the
      owner of the number of common stock purchase warrants (“Warrants”)
      which
      entitles the holder thereof to purchase, at any time during the period
      commencing on the Commencement Date (as defined herein) and ending on the
      Expiration Date (as defined herein), Fifty
      Thousand
      (50,000)
      fully
      paid and non-assessable shares of the Company’s common stock, par value $.0001
      (“Common
      Stock”),
      at a
      purchase price equal to the Exercise Price (as defined below) in lawful money
      of
      the United States of America in cash or securities, subject to adjustment as
      hereinafter provided. 

     

    1. WARRANT;
      EXERCISE PRICE.

     

    1.1 This
      Warrant is issued pursuant to an Employment Letter of Understanding, by and
      among DRTATTOFF, LLC and the Warrant Holder, effective as of June 16,
      2007.

     

    1.2 Each
      Warrant shall entitle the Warrant Holder to purchase one share of Common Stock,
      subject to adjustment as provided in Section 8 herein (individually, a
“Warrant
      Share”
      severally, the “Warrant
      Shares”).
      

     

    1.3 The
      purchase price payable upon exercise of each Warrant (the “Exercise
      Price”)
      shall
      be Eighty Cents ($0.80) per Warrant Share, or the equivalent thereof.
      Notwithstanding the foregoing, the Exercise Price and number of Warrant Shares
      purchasable pursuant to this Warrant are subject to adjustment as provided
      in
      Section 8. 

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    2. EXERCISE
      OF WARRANT; EXPIRATION DATE.
      

     

    2.1 This
      Warrant is exercisable at any time and from time to time commencing on February
      11, 2008 (“Commencement Date”) and ending at 5:00 p.m., Eastern Time on the date
      set forth above (the “Expiration Date”), in whole or from time to time in part,
      at the option of the Warrant Holder, upon surrender of this Warrant to the
      Company together with a duly completed Notice of Exercise in the form attached
      hereto and payment of an amount equal to the then applicable Exercise Price
      multiplied by the number of Warrant Shares then being purchased upon such
      exercise, except as provided in Section 2.1(b) hereunder. 

     

    2.2 Each
      exercise of this Warrant shall be deemed to have been effected immediately
      prior
      to the close of business on the day on which this Warrant shall have been
      surrendered to the Company as provided in Section 2.1. At such time, the person
      or persons in whose name or names any certificates for Warrant Shares shall
      be
      issuable upon such exercise as provided in Section 2.3 below shall be deemed
      to
      have become the holder or holders of record of the Warrant Shares represented
      by
      such certificates.

     

    2.3 Within
      five (5) business days after the exercise of the purchase right represented
      by
      this Warrant, the Company at its expense will use its reasonable best efforts
      to
      cause to be issued in the name of, and delivered to, the Warrant Holder, or,
      subject to the terms and conditions hereof, to such other individual or entity
      as such Warrant Holder (upon payment by such Warrant Holder of any applicable
      transfer taxes) may direct: 

     

    (a) a
      certificate or certificates for the number of full Warrant Shares to which
      such
      Warrant Holder shall be entitled upon such exercise , and 

     

    (b) in
      case
      such exercise is in part only, a new Warrant or Warrants (dated the date hereof)
      of like tenor, stating on the face or faces thereof the number of shares of
      Common Stock currently stated on the face of this Warrant minus the number
      of
      such Warrant Shares purchased by the Warrant Holder upon such exercise as
      provided in Section 2.2 (in each case prior to any adjustments made thereto
      pursuant to the provisions of this Warrant).

     

    3. REGISTRATION
      AND TRANSFER ON COMPANY BOOKS.
      

     

    3.1 The
      Company (or an agent of the Company) will maintain a register containing the
      names and addresses of the Warrant Holders. Any Warrant Holder may change its,
      his or her address as shown on the warrant register by written notice to the
      Company requesting such change. 

     

    3.2 The
      Company shall register upon its books any transfer of a Warrant upon surrender
      of same as provided in Section 5. 

     

    4. RESERVATION
      OF SHARES.
      The
      Company will at all times reserve and keep available, solely for issuance and
      delivery upon the exercise of this Warrant, such Warrant Shares and other stock,
      securities and property, as from time to time shall be issuable upon the
      exercise of this Warrant. As
      long
      as the Warrant shall be outstanding, the Company shall use its commercially
      reasonable efforts to cause all Warrant Shares issuable upon exercise of the
      Warrants to be listed (subject to official notice of issuance) on each Exchange
      (or, if applicable on Nasdaq, NASD OTC Bulletin Board or Pink Sheets, LLC or
      any
      successor electronic quotation service and trading market) on which the
      Company's shares of Common Stock are then listed and/or quoted, if
      any. 

     

    
      
         

      

      
        2

        
          

        

      

      
         

      

    

     

    5. EXCHANGE,
      TRANSFER, ASSIGNMENT OR LOSS OR MUTILATION OF WARRANTS.
      This
      Warrant is exchangeable, without expense, at the option of the Warrant Holder,
      upon presentation and surrender hereof to the Company for other warrants of
      different denominations entitling the holder thereof to purchase in the
      aggregate the same number of Warrant Shares purchasable hereunder. Subject
      to
      the terms of Sections 6 and 7, upon surrender of this Warrant to the Company
      at
      its principal office or at the office of its transfer agent, if any, with the
      Assignment Form annexed hereto duly executed and funds sufficient to pay any
      transfer tax, the Company shall, without charge, execute and deliver a new
      Warrant in the name of the assignee named in such instrument of assignment
      and
      this Warrant shall be promptly canceled. Subject to the terms of Sections 6
      and
      7, this Warrant may be divided or combined with other warrants which carry
      the
      same rights upon presentation hereof at the principal office of the Company
      together with a written notice specifying the names and denominations in which
      new Warrants are to be issued and signed by the Warrant Holder hereof. The
      term
“Warrant” as used herein includes any Warrants into which this Warrant may be
      divided or exchanged. Upon receipt by the Company of reasonable evidence of
      the
      ownership of and the loss, theft, destruction or mutilation of this Warrant
      and,
      in the case of loss, theft or destruction, of indemnity reasonably satisfactory
      to the Company, or, in the case of mutilation, upon surrender and cancellation
      of the mutilated Warrant, the Company shall execute and deliver in lieu thereof
      a new Warrant of like tenor and date representing an equal number of Warrants.
      

     

    6. LIMITATION
      ON EXERCISE AND SALES.
      

     

    (a)
       Each
      holder of this Warrant acknowledges that this Warrant and the Warrant Shares
      have not been registered under the Securities Act, as of the date of issuance
      hereof. This Warrant only may be transferred in compliance with this Section
      6
      and Section 7. The Company shall be under no obligation to issue the
shares
      of
      Common Stock
      covered
      by such exercise unless and until the Warrant Holder shall have executed the
      form of exercise annexed hereto that states that at the time of such exercise
      that it is then an “accredited investor” within the meaning of Rule 501 of
      Regulation D, is acquiring such shares
      of
      Common Stock for
      its
      own account, and will not transfer the Warrant Shares unless pursuant to an
      effective and current registration statement under the Securities Act or an
      exemption from the registration requirements of the Securities Act and any
      other
      applicable restrictions, in which event the Warrant Holder shall be bound by
      the
      provisions of a legend or legends to such effect that shall be endorsed upon
      the
      certificate(s) representing the Warrant Shares issued pursuant to such exercise.
      In such event, the Warrant Shares issued upon exercise hereof shall be imprinted
      with a legend in substantially the form provided in Section 7(b). 

     

    (b) Warrant
      Holder represents and warrants that it is acquiring this Warrant for its own
      account, for purposes of investment, and not with a view to, or for sale in
      connection with, any distribution thereof within the meaning of the Securities
      Act and the rules and regulations promulgated thereunder. Warrant Holder
      represents, warrants and agrees that it will not sell, exercise, transfer or
      otherwise dispose of this Warrant (or any interest therein) or any of the
      Warrant Shares purchasable upon exercise hereof, except pursuant to (i) an
      effective registration statement under the Securities Act and applicable state
      securities laws or (ii) an opinion of counsel, satisfactory to Company, that
      an
      exemption from registration under the Securities Act and such laws is available.
      Warrant Holder further acknowledges and agrees that Company is not required,
      legally or contractually, so to register or qualify the Warrant or such Warrant
      Shares or to take any action to make such an exemption available. Warrant Holder
      understands that Company will be relying upon the truth and accuracy of the
      representations and warranties contained in this Section 6 in issuing this
      Warrant and such Warrant Shares without first registering the issuance thereof
      under the Securities Act or qualifying or registering the issuance thereof
      under
      any state securities laws that may be applicable.

    

    
      
         

      

      
        3

        
          

        

      

      
         

      

    

    (c) Warrant
      Holder acknowledges that (i) there is not now, and there may not be in the
      future, any public market for the Warrant, (ii) although there currently is
      not
      a public trading market for the shares of Common Stock, there can be no
      assurance that any such market will be created and sustained, and (iii) there
      can be no assurance that Warrant Holder will be able to liquidate its investment
      in Company. Warrant Holder represents and warrants that it is familiar with
      and
      understands the terms and conditions of Rule 144 promulgated under the
      Securities Act.

    

    (d)
       Warrant
      Holder represents and warrants to Company that (i) it has such knowledge and
      experience in financial and business matters as is necessary to enable it to
      evaluate the merits and risks of any investments in Company and is not utilizing
      any other person to be a purchaser representative in connection with evaluation
      of such merits and risks; and (ii) it has no need for liquidity in an investment
      in Company and is able to bear the risk of that investment for an indefinite
      period and to afford a complete loss thereof.

    

    (e) Warrant
      Holder represents and warrants that it has had access to, and has been furnished
      with, all of the information it has requested from Company and has had an
      opportunity to review the books and records of Company and to discuss with
      management and members of the board of directors of Company the business and
      financial affairs of Company.

    

    (f)
       Warrant
      Holder agrees that at the time of each exercise of this Warrant, unless the
      issuance of Warrant Shares issuable thereupon is pursuant to an effective
      registration statement under the Securities Act and under applicable state
      blue
      sky laws, Warrant Holder will provide Company with a letter embodying the
      representations and warranties set forth in subsections (b) through (e), in
      form
      and substance reasonably satisfactory to Company, and agrees that the
      certificate(s) representing any Warrant Shares issued to it upon any exercise
      of
      this Warrant may bear such restrictive legend as Company may deem necessary
      to
      reflect the restricted status of such Warrant Shares under the Securities Act
      unless Company shall have received from Warrant Holder an opinion of counsel
      to
      Warrant Holder, reasonably satisfactory in form and substance to Company and
      its
      counsel, that such restrictive legend is not required.

     

    
      
         

      

      
        4

        
          

        

      

      
         

      

    

    7. TRANSFER
      RESTRICTIONS.

     

    (a) If,
      at the
time
      of
      the surrender of this Warrant in connection with any transfer of this Warrant,
      the transfer of this Warrant shall not be registered pursuant to an effective
      registration
      statement under the Securities Act
      and
under
      applicable state securities or blue sky laws, the Company may require, as a
      condition of allowing such transfer (i) that the Warrant Holder or transferee
      of
      this Warrant, as the case may be, furnish to the Company a written opinion
      of
      counsel (which opinion shall be in form, substance and scope customary for
      opinions of counsel in comparable transactions and reasonably satisfactory
      to
      counsel for the Company) to the effect that such transfer may be made
      without
      registration under the
      Securities Act and under applicable state securities or blue sky laws, (ii)
      that
      the holder or transferee execute and deliver to the Company an investment letter
      in form and substance acceptable to the Company, (iii) that transferee agree
      in
      writing with the Company to be bound by the terms and conditions of this Warrant
      applicable to the Warrant Holder and (iv) that the transferee be an “accredited
      investor” as defined in Regulation D promulgated under the Securities
      Act.

     

    (b) The
      Warrant Shares or other securities issuable on the exercise of the Warrant
      shall
      bear the following legend:

     

    THESE
      SECURITIES HAVE NOT BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION,
      OR THE SECURITIES COMMISSION OF ANY STATE, IN RELIANCE UPON AN EXEMPTION FROM
      REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
      ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN
      EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN
      AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
      REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE
      SECURITIES LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL TO THE TRANSFEROR
      TO
      SUCH EFFECT, THE SUBSTANCE OF WHICH SHALL BE REASONABLY ACCEPTABLE TO THE
      COMPANY.

     

    (c) The
      Holder acknowledges that the Warrant Shares acquired upon the exercise of this
      Warrant, if not registered, will have restrictions upon resale imposed by state
      and federal securities laws.

     

    8. ADJUSTMENT
      OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES DELIVERABLE.
      The
      Exercise Price and the number of Warrant Shares purchasable pursuant to each
      Warrant shall be subject to adjustment from time to time as hereinafter set
      forth in this Section 8: 

     

    (a) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall issue any additional shares of Common Stock as a dividend or subdivide
      the
      number of outstanding shares of Common Stock into a greater number of shares
      of
      Common Stock, then in either of such cases, the then applicable Exercise Price
      per Warrant Share purchasable pursuant to this Warrant in effect at the time
      of
      such action shall be proportionately reduced and the number of Warrant Shares
      at
      that time purchasable pursuant to this Warrant shall be proportionately
      increased; and conversely, in the event the Company shall reduce the number
      of
      outstanding shares of Common Stock by combining such shares of Common Stock
      into
      a smaller number of shares of Common Stock then, in such case, the then
      applicable Exercise Price per Warrant Share purchasable pursuant to this Warrant
      in effect at the time of such action shall be proportionately increased and
      the
      number of Warrant Shares at that time purchasable pursuant to this Warrant
      shall
      be proportionately decreased. If the Company shall, at any time during the
      life
      of this Warrant, declare a dividend payable in cash on its shares of Common
      Stock and shall at substantially the same time offer to its shareholders a
      right
      to purchase new shares of Common Stock from the proceeds of such dividend or
      for
      an amount substantially equal to the dividend, all shares of Common Stock so
      issued shall, for the purpose of this Warrant, be deemed to have been issued
      as
      a dividend. Any dividend paid or distributed upon the Common Stock in shares
      of
      any other class of securities convertible into shares of Common Stock shall
      be
      treated as a dividend paid in shares of Common Stock to the extent that shares
      of Common Stock are issuable upon conversion thereof.

     

    
      
         

      

      
        5

        
          

        

      

      
         

      

    

     

    (b) In
      case,
      prior to the expiration of this Warrant by exercise or by its terms, the Company
      shall be recapitalized by reclassifying its outstanding shares of Common Stock,
      (or the Company or a successor corporation shall consolidate or merge with
      or
      convey all or substantially all of its or of any successor corporation’s
      property and assets to any other corporation or corporations (any such other
      corporations being included within the meaning of the term “successor
      corporation” hereinbefore used in the event of any consolidation or merger of
      any such other corporation with, or the sale of all or substantially all of
      the
      property of any such other corporation to, another corporation or corporations),
      then, as a condition of such recapitalization, consolidation, merger or
      conveyance, lawful and adequate provision shall be made whereby the holder
      of
      this Warrant shall thereafter have the right to purchase, upon the basis and
      on
      the terms and conditions specified in this Warrant, in lieu of the Warrant
      Shares theretofore purchasable upon the exercise of this Warrant, such shares
      of
      stock, securities or assets, as may be issued or payable with respect to, or
      in
      exchange for, the number of Warrant Shares theretofore purchasable upon the
      exercise of this Warrant had such recapitalization, consolidation, merger,
      or
      conveyance not taken place, and the exercise price for which shall have been
      appropriately adjusted to reflect the number of securities which the Warrant
      Holder is entitled to purchase in exchange for such Warrant; and in any such
      event, the rights of the Warrant Holder to any adjustment in the number of
      Warrant Shares purchasable upon the exercise of this Warrant, as herein
      provided, shall continue and be preserved in respect of any stock which the
      Warrant Holder becomes entitled to purchase.

     

    (c) In
      case
      the Company at any time while this Warrant shall remain unexpired and
      unexercised shall sell all or substantially all of its property or dissolve,
      liquidate, or wind up its affairs, lawful provision shall be made as part of
      the
      terms of any such sale, dissolution, liquidation or winding up, so that the
      holder of this Warrant may thereafter receive upon exercise hereof in lieu
      of
      each Warrant Share that it would have been entitled to receive, the same kind
      and amount of any securities or assets as may be issuable, distributable or
      payable upon any such sale, dissolution, liquidation or winding up with respect
      to each Share of the Company, provided, however, that in any case of any such
      sale or of dissolution, liquidation or winding up, the right to exercise this
      Warrant shall terminate on a date fixed by the Company; such date so fixed
      to be
      not earlier than 5:00 p.m., Eastern Time, on the forty-fifth day next succeeding
      the date on which notice of such termination of the right to exercise this
      Warrant has been given by mail to the registered holder of this Warrant at
      its
      address as it appears on the books of the Company.

     

    
      
         

      

      
        6

        
          

        

      

      
         

      

    

     

    9. VOLUNTARY
      ADJUSTMENT BY THE COMPANY.
      The
      Company may, at its option, at any time during the term of the Warrants, reduce
      the then current Exercise Price to any amount deemed appropriate by the officers
      and directors of the Company and/or extend the date of the expiration of the
      Warrants. 

     

    10. RIGHTS
      OF THE HOLDER.
      The
      Warrant Holder shall not, by virtue hereof, be entitled to any rights of a
      shareholder in the Company, either at law or equity, and the rights of the
      Warrant Holder are limited to those expressed in this Warrant and are not
      enforceable against the Company except to the extent set forth herein. This
      Warrant does not entitle the Holder to any voting rights or other rights as
      a
      shareholder of the Company prior to the Exercise Date and then only with respect
      to the Warrant Shares to be issued with respect thereto. 

     

    11. NOTICES
      OF RECORD DATE.
      In
      case: 

     

    (a) the
      Company shall take a record of the holders of its shares of Common Stock (or
      other stock or securities at the time deliverable upon the exercise of this
      Warrant) for the purpose of entitling or enabling them to receive any dividend
      or other distribution, or to receive any right to subscribe for or purchase
      any
      shares of Common Stock or any other securities, or to receive any other right,
      or 

     

    (b) of
      any
      capital reorganization of the Company, any reclassification of the equity
      capital of the Company, any consolidation or merger of the Company with or
      into
      a corporation or other entity (other than a consolidation or merger in which
      the
      Company is the surviving entity), or any transfer of all or substantially all
      of
      the assets of the Company, or 

     

    (c) of
      the
      voluntary or involuntary dissolution, liquidation or winding-up of the Company,
      

     

    then,
      and
      in each such case, the Company will mail or cause to be mailed to the Warrant
      Holder a notice specifying, as the case may be, (i) the date on which a record
      is to be taken for the purpose of such dividend, distribution or right, and
      stating the amount and character of such dividend, distribution or right, or
      (ii) the effective date on which such reorganization, reclassification,
      consolidation, merger, transfer, dissolution, liquidation or winding-up is
      to
      take place, and the time, if any is to be fixed, as of which the holders of
      record of shares of Common Stock (or such other stock or securities at the
      time
      deliverable upon the exercise of this Warrant) shall be entitled to exchange
      their shares of Common Stock (or such other stock or securities) for securities
      or other property deliverable upon such reorganization, reclassification,
      consolidation, merger, transfer, dissolution, liquidation or winding-up. Such
      notice shall be mailed at least ten days prior to the record date or effective
      date for the event specified in such notice, provided that the failure to mail
      such notice shall not affect the legality or validity of any such action.

     

    
      
         

      

      
        7

        
          

        

      

      
         

      

    

     

    12. SUCCESSORS.
      The
      rights and obligations of the parties to this Warrant will inure to the benefit
      of and be binding upon the parties hereto and their respective heirs,
      successors, assigns, pledgees, transferees and purchasers. 

     

    13. CHANGE
      OR WAIVER.
      Any
      term of this Warrant may be changed or waived only by an instrument in writing
      signed by the party against whom enforcement of the change or waiver is sought.
      

     

    14. HEADINGS.
      The
      headings in this Warrant are for purposes of reference only and shall not limit
      or otherwise affect the meaning of any provision of this Warrant. Wherever
      possible, each provision of this Warrant shall be interpreted in such manner
      as
      to be effective and valid under applicable law, but if any provision of this
      Warrant shall be prohibited by or invalid under applicable law, such provision
      shall be ineffective to the extent of such prohibition or invalidity, without
      invalidating the remainder of such provisions or the remaining provisions of
      this Warrant.

     

    15. GOVERNING
      LAW.
      This
      Warrrant shall be governed by and construed in accordance with the laws of
      the
      State of Florida. Any action or litigation brought by either party against
      the
      other concerning the transactions contemplated by this Warrant shall be brought
      only in the state courts or in the federal courts located in the state of
      Florida prevailing party shall be entitled to recover from the other party
      its
      reasonable attorney’s fees and costs.

     

    16. MAILING
      OF NOTICES, ETC.
      All
      notices and other communications required or permitted hereunder shall be in
      writing and shall be deemed to have been duly given one (1) business day after
      delivery to an overnight carrier with instructions to deliver to the applicable
      address set forth below, or, if sent by facsimile, upon receipt of a
      confirmation of delivery: 

    

      
        	
                Registered
                  Holder:

              	
                To
                  his or her last known address as indicated on the Company’s books and
                  records.

              
	 	 
	
                The
                  Company:

              	
                Lifesciences
                  Opportunities Incorporated

              
	 	
                8500
                  Wilshire Blvd, Suite 105

              
	 	
                Beverly
                  Hills, CA 90211

              
	 	
                Attention:
                  Chief Executive Officer

              

      

    

    

    

    [Signature
      Page Follows]

     

    
      
         

      

      
        8

        
          

        

      

      
         

      

    

     

    IN
      WITNESS WHEREOF, the Company has caused this Warrant to be signed by its duly
      authorized officer as of the date first written above.

     

    
      	 	 	 
	 	Lifesciences
              Opportunities Incorporated
	 
 	 
 	 
 
	 	By:  	/s/ James
              Morel
	 	
              
Name:
              James Morel
	 	Title:
              Chief Executive Officer 

    
      
         

      

      
        9

        
          

        

      

      
         

      

    

    Notice
      of Exercise

    To
      Be
      Executed by the Warrant Holder

    In
      Order
      to Exercise Warrants

    

    TO:
      Lifesciences
      Opportunities Incorporated

    

    The
      undersigned hereby: (1) irrevocably subscribes for and offers to purchase
      _______ shares of Common Stock (“Shares”),
      of
Lifesciences
      Opportunities Incorporated,
      pursuant to Warrant No. ___________ heretofore issued to ____________ on
      _________________, 20___ and (2) encloses a cash payment of $__________
      representing the aggregate exercise price for such Shares. 

    

    The
      undersigned hereby represents and warrants to the Company that it is an
“Accredited Investor” within the meaning of Rule 501 of Regulation D promulgated
      under the Securities Act of 1933, as amended (the “Securities
      Act”),
      and
      is acquiring these securities for its own account and not with a view to, or
      for
      sale in connection with, any distribution thereof, nor with any present
      intention of distributing or selling the same. The undersigned further
      represents that it does not have any contract, agreement, understanding or
      arrangement with any person to sell, transfer or grant the Shares issuable
      under
      this Warrant. The undersigned understands that the shares it will be receiving
      are “restricted securities” under Federal securities laws inasmuch as they are
      being acquired from Lifesciences Opportunities Incorporated, in transactions
      not
      including any public offering and that under such laws, such shares may only
      be
      sold pursuant to an effective and current registration statement under the
      Securities Act or an exemption from the registration requirements of the
      Securities Act and any other applicable restrictions, in which event a legend
      or
      legends will be placed upon the certificate(s) representing the Shares issuable
      under this Warrant denoting such restrictions. The undersigned understands
      and
      acknowledges that the Company will rely on the accuracy of these representations
      and warranties in issuing the securities underlying the Warrant.

    

    [warrant
      notice of exercise signature page to follow]

     

    
      
         

      

      
        10

        
          

        

      

      
         

      

    

    [WARRANT
      NOTICE OF EXERCISE SIGNATURE PAGE]

     

    Date:  _________________________________________________________________________________________

    

    Warrant
      Holder Name: ____________________________________________________________________________

    

    Taxpayer
      Identification Number: ____________________________________________________________________

    

    By:
      __________________________________________________________________________________________

    

    Printed
      Name: __________________________________________________________________________________

    

    Title:  ________________________________________________________________________________________

    

    Address:
       _____________________________________________________________________________________

     

    Note:
      The
      above signature should correspond exactly with the name on the face of this
      Warrant or with the name of assignee appearing in assignment form below.

    

    AND,
      if
      said number of shares shall be less than the total number of shares purchasable
      under the Warrant, a new Warrant is to be issued in the name of said undersigned
      for the balance remaining of the shares purchasable thereunder less any fraction
      of a share paid in cash and delivered to the address stated above.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

    ASSIGNMENT
      FORM

    To
      be
      executed by the Warrant Holder

    In
      order
      to Assign Warrants

    

    FOR
      VALUE
      RECEIVED,____________________________________ hereby sell, assigns and transfer
      unto

     

    PLEASE
      INSERT SOCIAL SECURITY OR OTHER IDENTIFYING NUMBER

    

    
      	 

    

     

     

    
      	           
              
	       
	              
              

    

    (Please
      print or type name and address)

    

     

    ______________________
      of the Warrants represented by this Warrant, and hereby irrevocably constitutes
      and appoints ________________________ Attorney to transfer this Warrant on
      the
      books of the Company, with full power of substitution in the
      premises.

     

     

    
      	Dated:
              	           
              	 	              
              
	 	 	 	(Signature of Registered
              Holder)
	 	 	 	 	 

    

    

    In
      addition to executing this Assignment Form, the Warrant Holder and the
      transferee must comply with the other requirements for transfer set forth in
      Sections 6 and 7 of the Warrant.

    

     

    CERTIFICATION
      OF STATUS OF TRANSFEREE

    TO
      BE EXECUTED BY THE TRANSFEREE OF THIS WARRANT

    

    The
      undersigned transferee hereby certifies to the registered holder of this Warrant
      and to Lifesciences
      Opportunities Incorporated
      that the
      transferee is an “accredited investor” within the meaning of Rule 501 of
      Regulation D promulgated under the Securities Act of 1933, as
      amended.

    
       

      
        	Dated:
                	                     
                	 	                      
                    
	 	 	 	(Signature of
                Transferee)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00145-of-00352.parquet"}]]